Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Christina Aquilante

Concepts (356)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
30
2025
176
6.000
Why?
Pharmacogenomic Testing
16
2026
63
4.380
Why?
Thiazolidinediones
8
2016
142
2.520
Why?
Aryl Hydrocarbon Hydroxylases
10
2014
45
2.200
Why?
Heart Transplantation
9
2024
682
2.070
Why?
Polymorphism, Genetic
17
2019
612
2.040
Why?
Organ Transplantation
3
2024
244
1.630
Why?
Cytochrome P-450 CYP3A
8
2024
93
1.530
Why?
Precision Medicine
11
2025
462
1.460
Why?
Genotype
20
2025
1879
1.420
Why?
Tacrolimus
3
2024
192
1.370
Why?
Polymorphism, Single Nucleotide
11
2024
2240
1.360
Why?
Cytochrome P-450 CYP2C19
6
2024
29
1.280
Why?
Health Personnel
4
2021
754
1.200
Why?
Transplant Recipients
6
2024
177
1.160
Why?
Hypoglycemic Agents
11
2020
1412
1.140
Why?
Decision Support Systems, Clinical
2
2024
279
1.060
Why?
Graft Rejection
3
2024
516
1.050
Why?
Blood Pressure
8
2020
1765
1.040
Why?
Metabolic Syndrome
4
2016
364
0.980
Why?
Cytochrome P-450 CYP2D6
4
2022
33
0.950
Why?
Immunosuppressive Agents
6
2024
829
0.870
Why?
Pharmacists
3
2022
260
0.830
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
449
0.750
Why?
Cost-Benefit Analysis
3
2024
640
0.720
Why?
Gemfibrozil
2
2013
9
0.710
Why?
Sulfonylurea Compounds
3
2018
49
0.680
Why?
Adiponectin
2
2016
243
0.680
Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
20
0.680
Why?
Leukopenia
1
2021
33
0.680
Why?
Hypolipidemic Agents
2
2013
89
0.670
Why?
Dihydrouracil Dehydrogenase (NADP)
3
2026
5
0.660
Why?
Warfarin
4
2024
179
0.640
Why?
Mycophenolic Acid
1
2021
117
0.640
Why?
Desogestrel
5
2021
46
0.630
Why?
Organic Anion Transporters
2
2011
13
0.630
Why?
Platelet Aggregation Inhibitors
1
2024
499
0.610
Why?
Biological Specimen Banks
2
2024
137
0.610
Why?
Hypertension
3
2020
1272
0.600
Why?
Humans
83
2026
146342
0.580
Why?
Prescription Drugs
2
2020
110
0.570
Why?
Cytochrome P-450 CYP2C8
7
2014
14
0.560
Why?
Cardiologists
1
2018
45
0.560
Why?
Adult
43
2024
41087
0.540
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
46
0.530
Why?
Middle Aged
41
2024
36619
0.530
Why?
HIV Protease Inhibitors
4
2016
69
0.520
Why?
Physicians
3
2021
955
0.510
Why?
Ritonavir
4
2012
76
0.500
Why?
Academic Medical Centers
1
2020
561
0.480
Why?
Antimetabolites, Antineoplastic
3
2026
108
0.480
Why?
Polypharmacy
1
2017
94
0.460
Why?
Heart Failure
4
2017
2329
0.460
Why?
Male
48
2024
73396
0.460
Why?
Female
52
2024
79499
0.460
Why?
Fluorouracil
3
2026
231
0.460
Why?
Lectins
1
2016
44
0.460
Why?
Nonprescription Drugs
1
2016
68
0.460
Why?
Antiviral Agents
1
2021
779
0.440
Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.430
Why?
Attitude of Health Personnel
2
2020
1219
0.420
Why?
Cytochrome P-450 Enzyme System
2
2006
163
0.410
Why?
Contraceptive Agents, Female
3
2020
80
0.410
Why?
Medicare
1
2020
920
0.400
Why?
Death, Sudden, Cardiac
3
2021
242
0.390
Why?
Pediatrics
2
2021
1124
0.390
Why?
Blood Pressure Determination
1
2014
143
0.390
Why?
Chemokine CXCL5
3
2012
20
0.380
Why?
Heptanoic Acids
1
2013
67
0.370
Why?
Arrhythmias, Cardiac
3
2021
358
0.370
Why?
Pharmaceutical Preparations
3
2009
172
0.350
Why?
Pyrazines
1
2013
94
0.350
Why?
Resistin
2
2010
12
0.350
Why?
Pravastatin
1
2011
45
0.350
Why?
Pyrroles
1
2013
222
0.340
Why?
Anticoagulants
3
2024
746
0.340
Why?
Triazoles
1
2013
190
0.340
Why?
Dobutamine
3
2008
24
0.340
Why?
Diabetes Mellitus, Type 2
5
2020
2623
0.330
Why?
Health Knowledge, Attitudes, Practice
4
2021
1408
0.330
Why?
Retrospective Studies
15
2024
17438
0.330
Why?
Cross-Sectional Studies
8
2020
5899
0.320
Why?
Managed Care Programs
2
2022
137
0.320
Why?
Antidepressive Agents
2
2022
235
0.300
Why?
Mixed Function Oxygenases
2
2008
43
0.300
Why?
DNA
1
2016
1421
0.300
Why?
Aged
19
2024
26432
0.290
Why?
Drug Interactions
5
2017
405
0.290
Why?
Chromatography, Liquid
1
2010
453
0.280
Why?
Polymerase Chain Reaction
3
2006
1031
0.280
Why?
Health
1
2008
81
0.270
Why?
Cytokines
1
2016
2081
0.270
Why?
International Normalized Ratio
2
2024
55
0.260
Why?
Drug Prescriptions
4
2021
314
0.260
Why?
Chemokine CCL2
1
2008
112
0.260
Why?
Sulfonamides
1
2011
594
0.260
Why?
Receptors, Adrenergic, beta
1
2008
58
0.260
Why?
Mass Spectrometry
1
2010
729
0.260
Why?
Time Factors
8
2020
7109
0.250
Why?
Drug Implants
4
2021
83
0.250
Why?
Young Adult
13
2021
14330
0.250
Why?
Electronic Health Records
4
2026
1210
0.250
Why?
Heart Rate
3
2008
846
0.250
Why?
Matrix Metalloproteinase 8
1
2006
8
0.250
Why?
Haplotypes
5
2013
506
0.250
Why?
Sequence Analysis, DNA
4
2012
771
0.240
Why?
Blood Glucose
3
2016
2360
0.240
Why?
United States
12
2025
16136
0.240
Why?
Metoprolol
1
2006
26
0.240
Why?
Vitamin K Epoxide Reductases
3
2020
12
0.230
Why?
Clinical Laboratory Techniques
1
2006
96
0.230
Why?
Autonomic Nervous System
1
2006
82
0.230
Why?
Prospective Studies
7
2024
8123
0.230
Why?
Models, Biological
1
2013
1761
0.220
Why?
Blood Coagulation Factors
1
2006
71
0.220
Why?
Clinical Protocols
2
2017
282
0.220
Why?
Capecitabine
1
2025
56
0.220
Why?
Administration, Oral
4
2016
872
0.220
Why?
Genetic Variation
3
2019
996
0.210
Why?
Echocardiography
1
2008
645
0.210
Why?
Adrenergic beta-Antagonists
1
2006
253
0.210
Why?
Echocardiography, Stress
1
2004
29
0.210
Why?
Polymorphism, Restriction Fragment Length
1
2004
57
0.210
Why?
Cross-Over Studies
3
2013
615
0.210
Why?
Adverse Drug Reaction Reporting Systems
1
2024
81
0.200
Why?
Carrier Proteins
1
2008
728
0.200
Why?
United States Food and Drug Administration
1
2024
208
0.200
Why?
Follow-Up Studies
5
2024
5439
0.200
Why?
Biotransformation
2
2013
61
0.190
Why?
Cytochrome P-450 CYP2C9
4
2019
20
0.190
Why?
Metformin
1
2007
328
0.190
Why?
Cohort Studies
7
2021
6077
0.190
Why?
Alleles
6
2012
907
0.190
Why?
Waist Circumference
2
2016
142
0.190
Why?
Gene Frequency
4
2013
496
0.180
Why?
Dose-Response Relationship, Drug
4
2024
2022
0.170
Why?
Antimalarials
2
2013
35
0.170
Why?
Clinical Trials as Topic
1
2006
1064
0.170
Why?
Drug Dosage Calculations
1
2020
27
0.160
Why?
Calcineurin Inhibitors
1
2021
67
0.160
Why?
Aged, 80 and over
5
2024
8391
0.160
Why?
Pharmacogenomic Variants
2
2021
35
0.160
Why?
Egypt
1
2020
13
0.160
Why?
Atazanavir Sulfate
3
2016
41
0.160
Why?
Antibiotics, Antineoplastic
1
2021
141
0.160
Why?
Cytomegalovirus
1
2021
172
0.150
Why?
Area Under Curve
2
2013
335
0.150
Why?
No-Show Patients
1
2019
3
0.150
Why?
Menstruation Disturbances
1
2019
13
0.150
Why?
Blood Pressure Monitoring, Ambulatory
1
2020
69
0.150
Why?
Diabetes Mellitus
2
2024
1101
0.150
Why?
Smoking
1
2006
1486
0.150
Why?
Brain Chemistry
1
2000
122
0.150
Why?
Cytochrome P450 Family 3
1
2019
3
0.150
Why?
Cardiovascular Diseases
3
2024
2219
0.140
Why?
Colorado
3
2024
4595
0.140
Why?
Hemodynamics
1
2004
1114
0.140
Why?
Body Weight
2
2016
968
0.140
Why?
Oligopeptides
2
2012
264
0.140
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
344
0.140
Why?
Patients
1
2020
183
0.140
Why?
Morphine
1
2000
171
0.140
Why?
Sitagliptin Phosphate
2
2021
31
0.140
Why?
Child Health Services
1
2020
189
0.140
Why?
Progesterone
1
2019
214
0.140
Why?
Double-Blind Method
2
2016
2070
0.140
Why?
Ventricular Dysfunction
1
2018
16
0.130
Why?
Lipids
2
2016
714
0.130
Why?
Body Mass Index
3
2019
2458
0.130
Why?
Psychiatry
1
2020
191
0.130
Why?
Organophosphonates
2
2008
95
0.130
Why?
Bariatric Surgery
1
2021
250
0.130
Why?
Apyrase
1
2017
27
0.130
Why?
Treatment Outcome
7
2024
11821
0.120
Why?
Healthy Volunteers
2
2019
218
0.120
Why?
DNA Primers
3
2006
487
0.120
Why?
Pyrophosphatases
1
2016
28
0.120
Why?
Pyridines
2
2012
610
0.120
Why?
Chronic Disease
2
2017
1827
0.120
Why?
Ribavirin
1
2016
81
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
266
0.120
Why?
GPI-Linked Proteins
1
2016
81
0.110
Why?
Students, Pharmacy
1
2016
96
0.110
Why?
Patient Care
1
2016
120
0.110
Why?
Cardiology
1
2018
363
0.110
Why?
Circadian Rhythm
1
2020
515
0.110
Why?
Metabolic Clearance Rate
2
2013
115
0.110
Why?
Anti-HIV Agents
2
2016
914
0.110
Why?
Depression
2
2022
1575
0.110
Why?
Therapeutics
1
2015
14
0.110
Why?
Adenine
2
2008
339
0.110
Why?
Delivery of Health Care
1
2022
947
0.110
Why?
Surveys and Questionnaires
3
2026
6073
0.110
Why?
Voriconazole
1
2015
21
0.110
Why?
beta-Cyclodextrins
1
2015
32
0.110
Why?
Education, Pharmacy
1
2016
125
0.110
Why?
Diltiazem
1
2014
17
0.100
Why?
Patient Education as Topic
1
2019
770
0.100
Why?
HIV Infections
4
2016
3215
0.100
Why?
Renal Replacement Therapy
1
2015
102
0.100
Why?
Phenotype
3
2024
3206
0.100
Why?
Antifungal Agents
1
2015
153
0.100
Why?
Chromosomes, Human, Pair 10
1
2013
21
0.100
Why?
Surgical Procedures, Operative
1
2017
307
0.100
Why?
Antigens, CD
1
2017
560
0.100
Why?
Cardiomyopathies
1
2017
340
0.100
Why?
Reoperation
1
2016
645
0.100
Why?
Adolescent
6
2021
22557
0.090
Why?
Kidney Transplantation
1
2019
735
0.090
Why?
Neoplasms
2
2026
2954
0.090
Why?
Half-Life
1
2013
157
0.090
Why?
Medication Adherence
1
2017
535
0.090
Why?
Liver Transplantation
1
2019
751
0.090
Why?
Venous Thromboembolism
1
2017
332
0.090
Why?
Sirolimus
1
2014
282
0.090
Why?
Tissue Distribution
2
2014
334
0.090
Why?
Darunavir
1
2011
20
0.090
Why?
Practice Patterns, Physicians'
1
2020
1408
0.080
Why?
Self Care
1
2014
396
0.080
Why?
Genetic Association Studies
1
2013
379
0.080
Why?
Lung Transplantation
1
2014
326
0.080
Why?
Acquired Immunodeficiency Syndrome
1
2012
238
0.080
Why?
Reverse Transcriptase Inhibitors
2
2008
89
0.080
Why?
Insulin Resistance
2
2010
1247
0.080
Why?
Genetic Testing
2
2025
492
0.080
Why?
Prevalence
1
2017
2861
0.080
Why?
Cholesterol
1
2011
411
0.080
Why?
Patient Discharge
1
2016
997
0.070
Why?
Triglycerides
1
2011
527
0.070
Why?
ATP-Binding Cassette Transporters
1
2010
117
0.070
Why?
Leukocytes
2
2012
301
0.070
Why?
Lipoproteins
1
2010
165
0.070
Why?
Kidney Failure, Chronic
1
2015
589
0.070
Why?
Longitudinal Studies
1
2016
3017
0.070
Why?
Risk Assessment
3
2020
3712
0.070
Why?
Lung Diseases
1
2014
787
0.060
Why?
Incidence
2
2020
2936
0.060
Why?
Databases, Factual
3
2021
1493
0.060
Why?
Weight Gain
2
2021
562
0.060
Why?
Indinavir
1
2006
7
0.060
Why?
Linear Models
2
2019
857
0.060
Why?
Pyrimidinones
1
2007
124
0.060
Why?
Genetic Techniques
1
2006
64
0.060
Why?
Drug Delivery Systems
1
2010
377
0.060
Why?
Zidovudine
1
2006
75
0.060
Why?
Lamivudine
1
2006
63
0.060
Why?
Factor X
1
2006
26
0.060
Why?
Prothrombin
1
2006
25
0.060
Why?
Factor VII
1
2006
24
0.060
Why?
Chemokines, CXC
1
2006
68
0.060
Why?
Drug Utilization
1
2007
171
0.060
Why?
Reproducibility of Results
1
2014
3416
0.060
Why?
Base Sequence
2
2006
2123
0.060
Why?
Oxidation-Reduction
1
2009
1075
0.060
Why?
C-Reactive Protein
1
2008
429
0.060
Why?
Regression Analysis
1
2008
999
0.060
Why?
Biomarkers
3
2014
4340
0.060
Why?
Delayed-Action Preparations
1
2006
192
0.050
Why?
Health Care Surveys
1
2007
541
0.050
Why?
Prognosis
2
2014
4351
0.050
Why?
Pharmacovigilance
1
2024
25
0.050
Why?
Gene Expression Regulation
1
2014
2599
0.050
Why?
Mathematical Computing
1
2004
10
0.050
Why?
Gene Expression
1
2009
1463
0.050
Why?
Drug Labeling
1
2004
37
0.050
Why?
Risk Factors
3
2020
10921
0.050
Why?
Laboratories
1
2004
109
0.050
Why?
Infusions, Intravenous
1
2004
432
0.050
Why?
Algorithms
3
2024
1849
0.050
Why?
Reference Values
1
2004
796
0.050
Why?
Kidney
2
2008
1498
0.050
Why?
Socioeconomic Factors
1
2007
1327
0.040
Why?
Blood Coagulation
1
2024
267
0.040
Why?
Linagliptin
1
2021
5
0.040
Why?
Adamantane
1
2021
18
0.040
Why?
Administrative Claims, Healthcare
1
2021
29
0.040
Why?
Dipeptides
1
2021
55
0.040
Why?
Electronic Prescribing
1
2021
4
0.040
Why?
Uterine Hemorrhage
1
2021
41
0.040
Why?
Electrocardiography
1
2004
667
0.040
Why?
Drug Monitoring
1
2024
399
0.040
Why?
Protective Factors
1
2020
97
0.040
Why?
Drug Tolerance
1
2000
100
0.040
Why?
Costs and Cost Analysis
1
2020
217
0.040
Why?
Treatment Failure
1
2020
361
0.040
Why?
Homozygote
2
2012
197
0.040
Why?
Kaplan-Meier Estimate
1
2021
970
0.040
Why?
Animals
3
2008
38107
0.040
Why?
Sex Factors
1
2024
2107
0.030
Why?
Attitude
1
2020
253
0.030
Why?
Genomics
1
2024
853
0.030
Why?
Glipizide
1
2018
5
0.030
Why?
Glyburide
1
2018
30
0.030
Why?
Organic Anion Transport Protein 1
2
2008
6
0.030
Why?
Antineoplastic Agents
1
2009
2219
0.030
Why?
Proportional Hazards Models
1
2021
1331
0.030
Why?
Social Class
1
2019
260
0.030
Why?
Dexamethasone
1
2000
368
0.030
Why?
Liver
1
2006
1864
0.030
Why?
Indians, North American
1
2021
527
0.030
Why?
Self Report
1
2021
870
0.030
Why?
Feasibility Studies
1
2021
1135
0.030
Why?
Membrane Transport Proteins
2
2008
154
0.030
Why?
Self-Management
1
2019
207
0.030
Why?
Pharmaceutical Services
1
2016
76
0.030
Why?
Peru
1
2016
61
0.030
Why?
Anesthetics
1
2017
100
0.030
Why?
Diabetic Angiopathies
1
2018
265
0.030
Why?
Cause of Death
1
2018
456
0.030
Why?
Medicaid
1
2020
477
0.030
Why?
Tenofovir
2
2008
300
0.030
Why?
South Africa
1
2016
262
0.030
Why?
Alternative Splicing
1
2017
253
0.030
Why?
Hepatitis C, Chronic
1
2016
150
0.030
Why?
Perioperative Care
1
2017
235
0.030
Why?
HEK293 Cells
1
2017
750
0.030
Why?
Preoperative Care
1
2017
396
0.030
Why?
Receptors, Steroid
1
2014
41
0.030
Why?
Rats, Sprague-Dawley
1
2000
2537
0.030
Why?
Everolimus
1
2014
112
0.020
Why?
Demography
1
2014
274
0.020
Why?
Hypoglycemia
1
2018
490
0.020
Why?
Vasodilator Agents
1
2014
326
0.020
Why?
Age Factors
1
2019
3347
0.020
Why?
Heterozygote
1
2012
311
0.020
Why?
Rats
1
2000
5586
0.020
Why?
Genetic Loci
1
2012
273
0.020
Why?
Mental Disorders
1
2020
1148
0.020
Why?
Multivariate Analysis
1
2012
1543
0.020
Why?
Body Composition
1
2012
689
0.020
Why?
Insulin
1
2019
2525
0.020
Why?
Critical Illness
1
2015
908
0.020
Why?
Genetic Predisposition to Disease
1
2017
2488
0.020
Why?
Plasma
1
2009
222
0.020
Why?
Lopinavir
1
2007
30
0.020
Why?
PubMed
1
2006
15
0.010
Why?
Ribosomal Proteins
1
2006
93
0.010
Why?
Antiretroviral Therapy, Highly Active
1
2007
278
0.010
Why?
Pharmacology
1
2005
10
0.010
Why?
Molecular Sequence Data
1
2009
2838
0.010
Why?
Likelihood Functions
1
2005
138
0.010
Why?
Cardiotonic Agents
1
2005
96
0.010
Why?
RNA, Messenger
1
2012
2791
0.010
Why?
Mitochondrial Proteins
1
2006
263
0.010
Why?
Chromosome Mapping
1
2005
508
0.010
Why?
Genome
1
2006
307
0.010
Why?
Drug Therapy, Combination
1
2006
1036
0.010
Why?
Saccharomyces cerevisiae Proteins
1
2006
411
0.010
Why?
Hemorrhage
1
2008
825
0.010
Why?
Predictive Value of Tests
1
2008
2113
0.010
Why?
Models, Genetic
1
2005
540
0.010
Why?
Child
1
2020
22693
0.010
Why?
Pilot Projects
1
2006
1888
0.010
Why?
Computer Simulation
1
2005
1014
0.010
Why?
Case-Control Studies
1
2007
3647
0.010
Why?
Inflammation
1
2006
2919
0.010
Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)